What happened
NGeneBio updated the terms of a new share issuance to raise US$5.69M, about 64.5% of its market value.
For context, this raise equals about 64.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$5.69M |
| vs. market value | 64.5% |
| Filed | 2026-09-22, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260922000105 → open original filing |
Versions of this filing
- 2026-04-27Original
- 2026-07-02Amendment 1
- 2026-07-16Amendment 2
- 2026-07-20Amendment 3
- 2026-09-07Amendment 4
- 2026-09-22Amendment 5 (this page)
Source: DART. Information only, not investment advice.